Difficulty: Medium
Average Score: 90%
Practice
Which of the following is an example of humanized anti-human IL-6 receptor monoclonal antibody?
Correct answer
C
Rationale
In the context of pediatric cardiovascular nursing and pharmacology, understanding the mechanisms of different medications is crucial for safe and effective patient care.
The correct answer is C) Tocilizumab. Tocilizumab is an example of a humanized anti-human IL-6 receptor monoclonal antibody. It works by blocking the interleukin-6 (IL-6) receptor, thereby inhibiting the inflammatory response mediated by IL-6 in conditions such as systemic juvenile idiopathic arthritis and cytokine release syndrome. This targeted approach helps in managing inflammatory conditions by modulating the immune response.
A) Infliximab and B) Adalimumab are tumor necrosis factor-alpha (TNF-alpha) inhibitors used in conditions like inflammatory bowel disease and rheumatoid arthritis. D) Anakinra is an interleukin-1 receptor antagonist used in diseases such as rheumatoid arthritis and cryopyrin-associated periodic syndromes. These medications target different cytokines and receptors compared to IL-6 inhibition.
Understanding the specific mechanisms of action of these medications is essential for nurses caring for pediatric patients with cardiovascular conditions, as it guides appropriate medication administration, monitoring for side effects, and recognizing therapeutic responses. Additionally, knowing the correct classification of medications helps prevent errors in prescribing and administering drugs.
The correct answer is C) Tocilizumab. Tocilizumab is an example of a humanized anti-human IL-6 receptor monoclonal antibody. It works by blocking the interleukin-6 (IL-6) receptor, thereby inhibiting the inflammatory response mediated by IL-6 in conditions such as systemic juvenile idiopathic arthritis and cytokine release syndrome. This targeted approach helps in managing inflammatory conditions by modulating the immune response.
A) Infliximab and B) Adalimumab are tumor necrosis factor-alpha (TNF-alpha) inhibitors used in conditions like inflammatory bowel disease and rheumatoid arthritis. D) Anakinra is an interleukin-1 receptor antagonist used in diseases such as rheumatoid arthritis and cryopyrin-associated periodic syndromes. These medications target different cytokines and receptors compared to IL-6 inhibition.
Understanding the specific mechanisms of action of these medications is essential for nurses caring for pediatric patients with cardiovascular conditions, as it guides appropriate medication administration, monitoring for side effects, and recognizing therapeutic responses. Additionally, knowing the correct classification of medications helps prevent errors in prescribing and administering drugs.